Jane Street
CRDF icon

Jane Street’s Cardiff Oncology CRDF Stock Holding History

Jane Street’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Buy
607,900
+567,795
+1,416% +$901K ﹤0.01% 7026
2026
Q1 		$65K Sell
40,105
-92,745
-70% -$190K ﹤0.01% 10869
2025
Q4 		$373K Sell
132,850
-29,078
-18% -$67.5K ﹤0.01% 8357
2025
Q3 		$334K Buy
+161,928
New +$448K ﹤0.01% 8699
2025
Q1 		– Sell
-21,608
Closed -$93.8K – 9576
2024
Q4 		$93.8K Sell
21,608
-22,390
-51% -$70K ﹤0.01% 8782
2024
Q3 		$117K Sell
43,998
-52,824
-55% -$125K ﹤0.01% 8928
2024
Q2 		$215K Buy
96,822
+24,498
+34% +$92.3K ﹤0.01% 8282
2024
Q1 		$386K Buy
72,324
+50,635
+233% +$135K ﹤0.01% 7139
2023
Q4 		$32.1K Buy
+21,689
New +$26.2K ﹤0.01% 8859
2022
Q4 		– Sell
-20,461
Closed -$32K – 9264
2022
Q3 		$32K Buy
+20,461
New +$49.2K ﹤0.01% 9069
2022
Q1 		– Sell
-18,495
Closed -$65.4K – 10371
2021
Q4 		$111K Buy
+18,495
New +$110K ﹤0.01% 9182
2021
Q2 		– Sell
-27,057
Closed -$229K – 9839
2021
Q1 		$251K Buy
+27,057
New +$329K ﹤0.01% 7943
2018
Q2 		– Sell
-168
Closed -$4K – 5029
2018
Q1 		$4K Buy
+168
New +$4.14K ﹤0.01% 4725
2017
Q3 		– Sell
-150
Closed -$14K – 4506
2017
Q2 		$14K Buy
+150
New +$9.66K ﹤0.01% 4258
2017
Q1 		– Sell
-230
Closed -$35K – 4188
2016
Q4 		$35K Buy
+230
New +$53.7K ﹤0.01% 3940

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street's CRDF Position: Q2 2026 in Review

Jane Street increased its Cardiff Oncology (CRDF) stake by 1,416% in Q2 2026, buying an estimated $901K and bringing the position to 607,900 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #7026.

Jane Street first reported a position in CRDF in Q4 2016 and has held it in 15 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Jane Street held 607,900 shares of Cardiff Oncology worth $790K as of Q2 2026.
  • Jane Street bought 567,795 Cardiff Oncology shares in Q2 2026, an estimated $901K.
  • Cardiff Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7026 holding.
  • Jane Street first reported a position in Cardiff Oncology in Q4 2016 and has held it in 15 quarters since.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.